These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 16470080)

  • 1. Drug-induced metabolic syndrome.
    Wofford MR; King DS; Harrell TK
    J Clin Hypertens (Greenwich); 2006 Feb; 8(2):114-9. PubMed ID: 16470080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of real-world data on the effects of aripiprazole on weight and metabolic outcomes in adults.
    Citrome L; Kalsekar I; Baker RA; Hebden T
    Curr Med Res Opin; 2014 Aug; 30(8):1629-41. PubMed ID: 24666104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing weight gain and metabolic issues in patients treated with atypical antipsychotics.
    Henderson DC
    J Clin Psychiatry; 2008 Feb; 69(2):e04. PubMed ID: 18363448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between antihypertensive drugs and metabolic syndrome.
    Wofford MR; King DS
    Metab Syndr Relat Disord; 2004; 2(4):308-14. PubMed ID: 18370699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common Medications Which Lead to Unintended Alterations in Weight Gain or Organ Lipotoxicity.
    Medici V; McClave SA; Miller KR
    Curr Gastroenterol Rep; 2016 Jan; 18(1):2. PubMed ID: 26700070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormalities of glucose metabolism associated with atypical antipsychotic drugs.
    Newcomer JW
    J Clin Psychiatry; 2004; 65 Suppl 18():36-46. PubMed ID: 15600383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin for atypical antipsychotic-induced weight gain and glucose metabolism dysregulation: review of the literature and clinical suggestions.
    Hasnain M; Vieweg WV; Fredrickson SK
    CNS Drugs; 2010 Mar; 24(3):193-206. PubMed ID: 20155995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic complications of schizophrenia and antipsychotic medications--an updated review.
    Yogaratnam J; Biswas N; Vadivel R; Jacob R
    East Asian Arch Psychiatry; 2013 Mar; 23(1):21-8. PubMed ID: 23535629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schizophrenia, antipsychotics and metabolic disease.
    Reynolds GP
    J Psychopharmacol; 2007 Jun; 21(4):355-6. PubMed ID: 17656424
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolic syndrome and other factors associated with increased risk of diabetes.
    Streja D
    Clin Cornerstone; 2004; 6 Suppl 3():S14-29. PubMed ID: 15707266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weight gain and metabolic risks associated with antipsychotic medications in children and adolescents.
    Maayan L; Correll CU
    J Child Adolesc Psychopharmacol; 2011 Dec; 21(6):517-35. PubMed ID: 22166172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dyslipidemia and atypical antipsychotic drugs.
    Casey DE
    J Clin Psychiatry; 2004; 65 Suppl 18():27-35. PubMed ID: 15600382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperglycemia and antipsychotic medications.
    Haupt DW; Newcomer JW
    J Clin Psychiatry; 2001; 62 Suppl 27():15-26; discussion 40-1. PubMed ID: 11806485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Metabolic risk during antipsychotic treatment in patients with schizophrenia].
    Rzewuska M
    Psychiatr Pol; 2007; 41(4):457-72. PubMed ID: 18046977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of metabolic syndrome and cardiovascular risk after liver transplantation.
    Fatourou EM; Tsochatzis EA
    Lancet Gastroenterol Hepatol; 2019 Sep; 4(9):731-741. PubMed ID: 31387736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review.
    Newcomer JW
    CNS Drugs; 2005; 19 Suppl 1():1-93. PubMed ID: 15998156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity, diabetes, and the metabolic syndrome: new challenges in antipsychotic drug therapy.
    Caballero E
    CNS Spectr; 2003 Nov; 8(11 Suppl 2):19-22. PubMed ID: 14978454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Foreword. Importance of physical health in patients with schizophrenia.
    Höschl C
    Eur Psychiatry; 2010 Jun; 25 Suppl 2():S1-2. PubMed ID: 20620880
    [No Abstract]   [Full Text] [Related]  

  • 19. A systematic review of metabolic side effects related to the use of antipsychotic drugs in dementia.
    Atti AR; Ferrari Gozzi B; Zuliani G; Bernabei V; Scudellari P; Berardi D; De Ronchi D; Tarricone I; Menchetti M
    Int Psychogeriatr; 2014 Jan; 26(1):19-37. PubMed ID: 24103643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating the cardiometabolic syndrome: an opportunity to provide comprehensive cardiovascular risk reduction.
    Basile J; Houston M; Ferrario CM
    J Cardiometab Syndr; 2006; 1(5):358-61. PubMed ID: 17679795
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.